Peng Xu

Sr. Director and Head of Commercial Excellence at Lundbeck China

Speaker

Peng currently works as Sr. Director and Head of Commercial Excellence at Lundbeck China (mainland + HK). Lundbeck is a global pharmaceutical company specialized in developing innovative treatments for brain diseases.

Prior to this role, Peng held positions at management consulting (IQVIA), and multinational biopharma/biotech companies (Gilead, Celgene, Cubist Pharmaceuticals acquired by MSD) in global and affiliate settings.

Peng holds a Master degree from Boston University School of Public Health. Peng attended graduate research fellowship program as well as Artificial Intelligence executive training program at Harvard Medical School.